1. Home
  2. REZI vs GRFS Comparison

REZI vs GRFS Comparison

Compare REZI & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REZI
  • GRFS
  • Stock Information
  • Founded
  • REZI 2018
  • GRFS 1940
  • Country
  • REZI United States
  • GRFS Spain
  • Employees
  • REZI N/A
  • GRFS N/A
  • Industry
  • REZI Wholesale Distributors
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • REZI Industrials
  • GRFS Health Care
  • Exchange
  • REZI Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • REZI 6.1B
  • GRFS 5.9B
  • IPO Year
  • REZI N/A
  • GRFS 2006
  • Fundamental
  • Price
  • REZI $30.50
  • GRFS $8.74
  • Analyst Decision
  • REZI Buy
  • GRFS Hold
  • Analyst Count
  • REZI 3
  • GRFS 1
  • Target Price
  • REZI $34.67
  • GRFS $10.30
  • AVG Volume (30 Days)
  • REZI 1.7M
  • GRFS 740.8K
  • Earning Date
  • REZI 11-05-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • REZI N/A
  • GRFS 1.63%
  • EPS Growth
  • REZI N/A
  • GRFS N/A
  • EPS
  • REZI N/A
  • GRFS 0.64
  • Revenue
  • REZI $7,435,000,000.00
  • GRFS $8,821,017,248.00
  • Revenue This Year
  • REZI $13.22
  • GRFS $5.31
  • Revenue Next Year
  • REZI $3.40
  • GRFS $6.02
  • P/E Ratio
  • REZI N/A
  • GRFS $16.90
  • Revenue Growth
  • REZI 15.45
  • GRFS 7.31
  • 52 Week Low
  • REZI $14.18
  • GRFS $6.19
  • 52 Week High
  • REZI $45.29
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • REZI 21.48
  • GRFS 37.46
  • Support Level
  • REZI $29.21
  • GRFS $8.21
  • Resistance Level
  • REZI $31.49
  • GRFS $9.90
  • Average True Range (ATR)
  • REZI 1.42
  • GRFS 0.31
  • MACD
  • REZI -1.71
  • GRFS -0.07
  • Stochastic Oscillator
  • REZI 8.02
  • GRFS 31.28

About REZI Resideo Technologies Inc.

Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: